On Air Now

Current Show

America Now with Andy Dean   8:00 PM - 11:00 PM

Call America Now at 877-927-2639 between 5pm and 8pm

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 550 AM Wausau, WI 99.9 FM Stevens Point, WI

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
40° Feels Like: 33°
Wind: WNW 13 mph Past 24 hrs - Precip: 0.26”
Current Radar for Zip

Tonight

Rain 37°

Tomorrow

PM Showers 58°

Sat Night

Partly Cloudy 31°

Alerts

European regulators reject Vivus obesity drug

(Reuters) - Vivus Inc said European regulators recommended that its obesity pill not be approved, citing potential safety concerns related to the long-term use of the drug.

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) raised concerns over heart risks and birth defects and the drug Qsiva's use by patients for whom it was not indicated.

Vivus, which announced in late September that it was expecting a negative response, said it intends to appeal the panel opinion and request a re-examination of the decision by the CHMP.

The drug was launched in the United States in September under the brand name Qsymia, becoming the first new diet pill on the market in over a decade.

Vivus shares, which have fallen 11 percent since the September warning, were down 2 percent at $20.70 in extended trade. They closed at $21.06 on the Nasdaq on Thursday.

(Reporting by Balaji Sridharan in Bangalore, Editing by Anthony Kurian)

Comments